D-1255-2020 Class I Terminated
FDA drug recall D-1255-2020 was initiated by Avet Pharmaceuticals, Inc. on March 23, 2020 and is designated Class I. Reason for recall: Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules. The recall status is terminated (terminated August 23, 2022). Affected quantity: 4,444 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- April 15, 2020
- Initiation Date
- March 23, 2020
- Termination Date
- August 23, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,444 bottles
Product Description
Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-017-01
Reason for Recall
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Distribution Pattern
Distributed Nationwide in the US
Code Information
Lot # H190666, Exp JUL 2022